The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Polymer Nanoformulation of Sorafenib and All-Trans Retinoic Acid for Synergistic Inhibition of Thyroid Cancer
|
---|---|
Published in |
Frontiers in Pharmacology, February 2020
|
DOI | 10.3389/fphar.2019.01676 |
Pubmed ID | |
Authors |
Shijie Li, Shujun Dong, Weiguo Xu, Yang Jiang, Zhongmin Li |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 4 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 75% |
Scientists | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 26 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 4 | 15% |
Student > Master | 3 | 12% |
Student > Postgraduate | 2 | 8% |
Student > Bachelor | 2 | 8% |
Lecturer > Senior Lecturer | 1 | 4% |
Other | 2 | 8% |
Unknown | 12 | 46% |
Readers by discipline | Count | As % |
---|---|---|
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 19% |
Medicine and Dentistry | 3 | 12% |
Biochemistry, Genetics and Molecular Biology | 3 | 12% |
Environmental Science | 1 | 4% |
Business, Management and Accounting | 1 | 4% |
Other | 1 | 4% |
Unknown | 12 | 46% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 February 2020.
All research outputs
#15,069,113
of 23,191,112 outputs
Outputs from Frontiers in Pharmacology
#5,381
of 16,602 outputs
Outputs of similar age
#255,299
of 449,966 outputs
Outputs of similar age from Frontiers in Pharmacology
#176
of 465 outputs
Altmetric has tracked 23,191,112 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,602 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 449,966 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 465 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.